Data from: Global report on diabetes [Database on the internet] WHO deposited.2016

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.

Article  PubMed  Google Scholar 

Kononenko IV, Smirnova OM, Mayorov AY, Shestakova MV. Classification of diabetes. World Health Organization 2019. What’s new? Diabetes Mellitus. 2020;23(4):329–39.

Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. Plos Med. 2008;5(1): e20.

Article  PubMed  PubMed Central  Google Scholar 

Organization WH. Addressing diabetes as a public health challenge in the Eastern Mediterranean Region. World Health Organization.Regional Office for the Eastern Mediterranean. 2021.

Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20(1):166.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action. World J Diabetes. 2021;12(9):1401–25.

Article  PubMed  PubMed Central  Google Scholar 

Lai D, Wang D, McGillivray M, Baajour S, Raja AS, He S. Assessing the quality of randomization methods in randomized control trials. Healthcare (Amsterdam, Netherlands). 2021;9(4): 100570.

PubMed  Google Scholar 

Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ (Clin Res Ed). 1996;313(7057):570–1.

Article  CAS  Google Scholar 

Allen TW. Guide to clinical preventive services. Report of the US Preventive Services Task Force. J Am Osteopathic Assoc. 1991;91(3):281–9.

CAS  Google Scholar 

Moher D, Altman DG, Schulz KF, Elbourne DR. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. CMAJ. 2004;171(4):349–50.

Article  PubMed  PubMed Central  Google Scholar 

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (London, England). 1998;352(9128):609–13.

Article  CAS  PubMed  Google Scholar 

Altman DG, Simera I. A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. J R Soc Med. 2016;109(2):67–77.

Article  PubMed  PubMed Central  Google Scholar 

International Committee of Medical Journal Editors. http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-forsubmission.html. Accessed 11 Oct 2018.

Franco JVA, Arancibia M, Meza N, Madrid E, Kopitowski K. Clinical practice guidelines: Concepts, limitations and challenges. Medwave. 2020;20(3): e7887.

Article  PubMed  Google Scholar 

Nagy E, Watine J, Bunting PS, Onody R, Oosterhuis WP, Rogic D, et al. Do guidelines for the diagnosis and monitoring of diabetes mellitus fulfill the criteria of evidence-based guideline development? Clin Chem. 2008;54(11):1872–82.

Article  CAS  PubMed  Google Scholar 

Natsch S, van der Meer JW. The role of clinical guidelines, policies and stewardship. J Hosp Infect. 2003;53(3):172–6.

Article  CAS  PubMed  Google Scholar 

Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials The CONSORT statement. Jama. 1996;276(8):637–9.

Article  CAS  PubMed  Google Scholar 

Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clin Res Ed). 2010;340: c332.

Article  Google Scholar 

Zaccardi F, Davies MJ, Khunti K. The present and future scope of real-world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future? Diabetes Obes Metab. 2020;22(Suppl 3):21–34.

Article  PubMed  Google Scholar 

Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872–94.

Article  PubMed  PubMed Central  Google Scholar 

Montori VM, Wang YG, Alonso-Coello P, Bhagra S. Systematic evaluation of the quality of randomized controlled trials in diabetes. Diabetes Care. 2006;29(8):1833–8.

Article  PubMed  Google Scholar 

Schlesinger M, Grob R, Shaller D. Using Patient-Reported Information to Improve Clinical Practice. Health Serv Res. 2015;50 Suppl 2(Suppl 2):2116–54.

Article  PubMed  Google Scholar 

Gohari F, Baradaran HR, Tabatabaee M, Anijidani S, MohammadpourTouserkani F, Atlasi R, et al. Quality of reporting randomized controlled trials (RCTs) in diabetes in Iran; a systematic review. J Diabetes Metab Disord. 2015;15(1):36.

Article  PubMed  Google Scholar 

Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10(1):28–55.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed). 2021;372: n71.

Google Scholar 

Azadbakht L, Fard NR, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care. 2011;34(1):55–7.

Article  CAS  PubMed  Google Scholar 

Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008;31(4):648–54.

Article  CAS  PubMed  Google Scholar 

MalekshahiMoghadam A, Saedisomeolia A, Djalali M, Djazayery A, Pooya S, Sojoudi F. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients. Singapore Med J. 2012;53(9):615–9.

Google Scholar 

Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, et al. Daily consumption of vitamin D–or vitamin D+ calcium–fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr. 2011;93(4):764–71.

Article  CAS  PubMed  Google Scholar 

Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res: PTR. 2006;20(12):1036–9.

Article  CAS  PubMed  Google Scholar 

Huseini HF, Darvishzadeh F, Heshmat R, Jafariazar Z, Raza M, Larijani B. The clinical investigation of Citrullus colocynthis (L.) schrad fruit in treatment of Type II diabetic patients: a randomized, double blind, placebo-controlled clinical trial. Phytother Res : PTR. 2009;23(8):1186–9.

Article  PubMed  Google Scholar 

Rahbar AR, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr. 2005;59(4):592–6.

Article  CAS  PubMed  Google Scholar 

Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology. 2009;116(10):1943–8.

Article  PubMed  Google Scholar 

Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol. 2009;19(5):848–52.

Article  PubMed  Google Scholar 

Mirshahi A, Roohipoor R, Lashay A, Mohammadi SF, Abdoallahi A, Faghihi H. Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Eur J Ophthalmol. 2008;18(2):263–9.

Article  CAS  PubMed  Google Scholar 

Akbari A, Moodi H, Ghiasi F, Sagheb HM, Rashidi H. Effects of vacuum-compression therapy on healing of diabetic foot ulcers: randomized controlled trial. J Rehabil Res Dev. 2007;44(5):631–6.

Article  PubMed  Google Scholar 

Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA. 2009;302(9):977–84.

Article  CAS  PubMed  Google Scholar 

Yordanov Y, Dechartres A, Porcher R, Boutron I, Altman DG, Ravaud P. Avoidable waste of research related to inadequate methods in clinical trials. BMJ (Clin Res Ed). 2015;350: h809.

Google Scholar 

Koretz RL. Assessing the Evidence in Evidence-Based Medicine. Nutr Clin Pract. 2019;34(1):60–72.

Article  PubMed  Google Scholar 

Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hill AB. The reasons for writing. BMJ (Clin Res Ed). 1965;2(870):20790709.

Google Scholar 

Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1:60.

Article